Xu, J., Wang, X., & Qu, P. (2022, May). Comparing and Evaluating Five-Day Chemotherapy Agents Actinomycin D and Methotrexate in Low-Risk Post-Molar Gestational Trophoblastic Neoplasia: A Retrospective Analysis. Clinical and Experimental Obstetrics & Gynecology.
Chicago Style (17th ed.) CitationXu, Juan, Xinmei Wang, and Pengpeng Qu. "Comparing and Evaluating Five-Day Chemotherapy Agents Actinomycin D and Methotrexate in Low-Risk Post-Molar Gestational Trophoblastic Neoplasia: A Retrospective Analysis." Clinical and Experimental Obstetrics & Gynecology May. 2022.
MLA (9th ed.) CitationXu, Juan, et al. "Comparing and Evaluating Five-Day Chemotherapy Agents Actinomycin D and Methotrexate in Low-Risk Post-Molar Gestational Trophoblastic Neoplasia: A Retrospective Analysis." Clinical and Experimental Obstetrics & Gynecology, May. 2022.
